sequenom inc (SQNM:NASDAQ GS)
Paul V. Maier M.B.A.
Former Chief Financial Officer, Sequenom Inc.
|Age||Total Calculated Compensation||This person is connected to 59 board members in 6 different organizations across 11 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Paul V. Maier, M.B.A., has been an Independent Financial Consultant since February 2007. Mr. Maier has over 20 years of experience as a senior executive in biotechnology and pharmaceutical companies. He served as the Chief Financial Officer of Sequenom Inc. from June 2010 to June 10, 2014. Mr. Maier where he was instrumental in raising more than $360 million in equity and debt financing and commercializing Sequenom’s molecular diagnostics segment. He served as Chief ...
3595 John Hopkins CourtPhone: 858-202-9000
San Diego, California 92121
Board Members Memberships*
Independent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Governance Committee
Director, Chairman of Audit Committee, Member of Special Committee and Member of Finance & Transactions Committee
Director, Chairman of Audit Committee and Member of Corporate Governance/Nominating Committee
Independent Director, Member of Audit Committee and Member of Nominating & Governance Committee
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Pennsylvania State University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Rajiv Kanishka Liyanaarchchie De Silva||Chief Executive Officer, President and Director|
Endo International plc
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Andrew Philip Witty||Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee|
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|$1.5M||Compensation as of Fiscal Year 2014.|